Written in February 2015, an edited version of this blog was published in the Spring Issue of Baseline magazine. In the UK, 6,000 people were newly diagnosed with HIV in 2013, down from the 7,890 peak in 2005. This decrease masks an evolving epidemic with
It has now been 6 months since the PROUD and IPERGAY clinical studies investigating Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection had to change course due to the success of the antiretrovirals (ARV) used in these trials to prevent HIV acquisition in HIV
In a recent BMJ Blog Dr Rupert Whitaker cast a critical eye on Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection, questioning its role as a public health intervention. The piece is challenging and although it rightly emphasises the need for a carefully planned
On October 16 the PROUD Study Team announced that all participants enrolled in this pilot trial of daily Pre-Exposure Prophylaxis (PrEP) in the UK will be offered immediate PrEP. This was a challenging decision for the ANRS-led IPERGAY study which is investigating the efficacy of
Today’s announcement that all participants in the PROUD pilot study, which investigates a number of questions surrounding the use of PrEP by gay men, will be offered PrEP is both a source of relief and concern. Relief, because we knew that PrEP works before the